• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织因子及其在全血、血浆和微粒中的检测。

Tissue factor and its measurement in whole blood, plasma, and microparticles.

机构信息

Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599, USA.

出版信息

Semin Thromb Hemost. 2010 Nov;36(8):865-75. doi: 10.1055/s-0030-1267040. Epub 2010 Nov 3.

DOI:10.1055/s-0030-1267040
PMID:21049387
Abstract

Tissue factor (TF) is a transmembrane protein that initiates coagulation following contact with factor VII/VIIa. Recent experimental evidence, in particular from animal models, suggests an important role for circulating TF in thrombosis. This has led to a growing interest in the measurement of TF in whole blood and in cell-free plasma, where functionally active TF is carried on cell-derived microparticles. In this review, we address the range of assays for measuring circulating TF antigen and activity that have been published. We comment on some of the crucial preanalytical and analytical variables that influence the results and their interpretation.

摘要

组织因子(TF)是一种跨膜蛋白,在与因子 VII/VIIa 接触后启动凝血。最近的实验证据,特别是来自动物模型的证据,表明循环 TF 在血栓形成中起着重要作用。这导致人们对全血和无细胞血浆中 TF 的测量越来越感兴趣,在无细胞血浆中,功能活跃的 TF 存在于细胞衍生的微粒上。在这篇综述中,我们讨论了已发表的用于测量循环 TF 抗原和活性的一系列检测方法。我们还评论了一些影响结果及其解释的关键分析前和分析变量。

相似文献

1
Tissue factor and its measurement in whole blood, plasma, and microparticles.组织因子及其在全血、血浆和微粒中的检测。
Semin Thromb Hemost. 2010 Nov;36(8):865-75. doi: 10.1055/s-0030-1267040. Epub 2010 Nov 3.
2
Microparticle-associated tissue factor activity measured with the Zymuphen MP-TF kit and the calibrated automated thrombogram assay.使用Zymuphen MP-TF试剂盒和校准自动血栓图分析法测量的微粒相关组织因子活性。
Blood Coagul Fibrinolysis. 2012 Sep;23(6):520-6. doi: 10.1097/MBC.0b013e328354a256.
3
[Biology and physiopathology of tissue factor and its relevance for cardiovascular diseases].[组织因子的生物学与病理生理学及其与心血管疾病的相关性]
Ital Heart J Suppl. 2003 Jul;4(7):559-68.
4
Use of immuno-magnetic beads for direct capture of nanosized microparticles from plasma.使用免疫磁珠直接从血浆中捕获纳米级微粒。
Blood Coagul Fibrinolysis. 2012 Apr;23(3):244-50. doi: 10.1097/MBC.0b013e3283502924.
5
Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis.血液凝固外源性途径在止血和血栓形成中的作用。
Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1687-93. doi: 10.1161/ATVBAHA.107.141911. Epub 2007 Jun 7.
6
Tissue factor-bearing microparticles and cancer.携带组织因子的微粒与癌症
Semin Thromb Hemost. 2008 Mar;34(2):195-8. doi: 10.1055/s-2008-1079260.
7
Increased expression of TF on monocytes, but decreased numbers of TF bearing microparticles in blood from patients with acute myocardial infarction.急性心肌梗死患者血液中单核细胞上组织因子(TF)表达增加,但携带TF的微粒数量减少。
Eur J Haematol. 2009 Oct;83(4):387-8. doi: 10.1111/j.1600-0609.2009.01306.x. Epub 2009 Jun 25.
8
Differential ability of tissue factor antibody clones on detection of tissue factor in blood cells and microparticles.组织因子抗体克隆在血细胞和微粒体中检测组织因子的差异能力。
Thromb Res. 2012 Sep;130(3):538-46. doi: 10.1016/j.thromres.2012.06.001. Epub 2012 Jun 23.
9
Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.血浆微粒体中组织因子促凝活性在早期前列腺癌患者中增加。
Thromb Haemost. 2009 Jun;101(6):1147-55.
10
Role of tissue factor in hemostasis and thrombosis.组织因子在止血和血栓形成中的作用。
Blood Cells Mol Dis. 2006 Mar-Apr;36(2):104-7. doi: 10.1016/j.bcmd.2005.12.008. Epub 2006 Feb 7.

引用本文的文献

1
Associations of tissue factor and tissue factor pathway inhibitor with organ dysfunctions in septic shock.组织因子和组织因子途径抑制剂与感染性休克器官功能障碍的关系。
Sci Rep. 2024 Jun 24;14(1):14468. doi: 10.1038/s41598-024-65262-3.
2
Angiopoietin2 is associated with coagulation activation and tissue factor expression in extracellular vesicles in COVID-19.血管生成素2与COVID-19患者细胞外囊泡中的凝血激活和组织因子表达有关。
Front Med (Lausanne). 2024 May 13;11:1367544. doi: 10.3389/fmed.2024.1367544. eCollection 2024.
3
Extracellular vesicles in venous thromboembolism and pulmonary hypertension.
静脉血栓栓塞症和肺动脉高压中的细胞外囊泡。
J Nanobiotechnology. 2023 Nov 30;21(1):461. doi: 10.1186/s12951-023-02216-3.
4
A sensitive tissue factor activity assay determined by an optimized thrombin generation method.一种优化的凝血酶生成法测定的敏感组织因子活性测定法。
PLoS One. 2023 Jul 19;18(7):e0288918. doi: 10.1371/journal.pone.0288918. eCollection 2023.
5
Evaluation of four commercial ELISAs to measure tissue factor in human plasma.评估四种用于检测人血浆中组织因子的商业酶联免疫吸附测定法。
Res Pract Thromb Haemost. 2023 Mar 28;7(3):100133. doi: 10.1016/j.rpth.2023.100133. eCollection 2023 Mar.
6
Tissue factor activity of small and large extracellular vesicles in different diseases.不同疾病中小细胞外囊泡和大细胞外囊泡的组织因子活性
Res Pract Thromb Haemost. 2023 Mar;7(3):100124. doi: 10.1016/j.rpth.2023.100124. Epub 2023 Mar 15.
7
Tissue factor in COVID-19-associated coagulopathy.COVID-19 相关凝血病中的组织因子。
Thromb Res. 2022 Dec;220:35-47. doi: 10.1016/j.thromres.2022.09.025. Epub 2022 Oct 1.
8
Tissue factor release following traumatic brain injury drives thrombin generation.创伤性脑损伤后组织因子的释放会驱动凝血酶的生成。
Res Pract Thromb Haemost. 2022 Jun 8;6(4):e12734. doi: 10.1002/rth2.12734. eCollection 2022 May.
9
Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles.方法学在心血管研究中外泌体的鉴定和特征分析:从外泌体到微囊泡。
Cardiovasc Res. 2023 Mar 17;119(1):45-63. doi: 10.1093/cvr/cvac031.
10
Evaluation of a new bead-based assay to measure levels of human tissue factor antigen in extracellular vesicles in plasma.评估一种基于微珠的新检测方法,用于测量血浆细胞外囊泡中人类组织因子抗原的水平。
Res Pract Thromb Haemost. 2022 Mar 4;6(2):e12677. doi: 10.1002/rth2.12677. eCollection 2022 Feb.